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Pathology.-A brief review of the pathological features of argentaffinomata or carcinoids is justified by the recent interest which has been aroused in these uncommon tumours by the discovery that they secrete 5-hydroxytryptamine (5-HT). An excess of this substance in the circulation is responsible, in some cases, for a striking clinical syndrome (Bi6rck et al., 1952; Thorson et al., 1954) .
Incidence.-The tumours are most commonly encountered in the appendix but in this situation they are usually of no great importance since they are removed when too small to cause endocrine effects and to metastasize. Although these tumours have been reported throughout the alimentary tract, in the gall-bladder, biliary passages, pancreas, and in ovarian teratomata, the most common site outside the appendix is the ileum where they are often multiple.
Carcinoids occur at all ages except in the appendix where juveniles are usually affected. In my own series of non-appendicular cases the age extremes are 19 years and 83 years. It should be remembered, however, that the slow growth of these tumours probably vitiates the correct assessment of age incidence. ,Etiology.-The tumours have not been produced experimentally and there is no evidence of any external carcinogen being involved. The facts, that they occur at an early age and that they have been associated in some instances with developmental anomalies elsewhere in the body (Spain, 1955) , have been used to support the view that carcinoids are developmental tumours. Many cases do, however, -satisfy the us-ual criteria of malignant neoplasia and this interpretation seems the most reasonable at the moment.
Histogenesis.-The tumours are generally considered to arise from the argentaffin (or Kulschitsky) cells of the alimentary tract. These cells lying deep in the crypts are seen, after formalin fixation, to contain granules which characteristically give the following main histochemical reactions: (1) they spontaneously reduce silver salts; (2) they give a striking orange colour with the diazonium reaction (Pearse, 1953) this method has been found most useful in routine practice; and (3) they fluoresce brilliantly in ultraviolet light. By histochemical methods Barter and Pearse (1955) have shown that the Kulschitsky cells almost certainly contain 5-hydroxytryptamine in some form.
Appearances.-ln the ileum the commonly encountered features are multiplicity, a yellow colour, a tendency te occupy the submucous layers without ulcerating into the lumen and, frequently, an association with a greater amount of hypertrophy of the bowel muscle than might be anticipated on the basis of mechanical obstruction alone. The naked-eye characters are not diagnostic and recourse must be made to microscopy in many cases. Dukes (1946) has shown that most of the carcinoids in the rectum and colon are benign and mimic in appearance the more common simple neoplasms of the region, often presenting as sessile projections into the lumen. In contrast, Gabriel and Morson (1956) have described a deeply ulcerating argentaffinoma of the rectum with lymphatic and liver metastases.
Histology.-In the majority of cases the morphological features are characteristic. The cells are in compact, rounded, aggregates often showing a tendency to peripheral palisading. Tubular and acinar formations are usually not prominent. With henimalum and eosin staining the round uniform nuclei show a characteristic fine dusting of the chromatin while the specific granules, in highest concentration in the peripheral cells of the aggregates, are eosinophilic. Positive results are usually obtained with the histochemical reactions already mentioned. Some cases may lack these characteristics, however, and histological diagnosis. even with the special stains, may be difficult or impossible. Gabriel and Morson (1956) suggest that the large bowel carcinoids are somewhat different from those occurring at other sites in that they show poorer specific granulation and have a tendency to form tubules and acini.
Criteria of malignancy and metastases.-The smallest tumours show infiltrative features and often local lymphatic permeation but again the characteristic slowness of growth means that, in practice, the majority behave in a benign fashion despite the histological indications of malignancy. This is true particularly of the appendicular and large intestinal sites. The ileal carcinoids often have metastasized to the local lymph nodes and even to the liver, by the time laparotomy is done, but in such cases, the slow growth of the metastases is often so prominent a feature that very long survival periods are the rule.
Transccelomic spread to the ovaries and also systemic dissemination to bones and other organs occur.
Studies on the excretion of5-hydroxyindole acetic acid (5-HIAA) in cases ofargentaffinoma.-5-HT is derived from the essential amino acid tryptophan and is broken down by the widespread enzyme amine oxidase to give 5-HIAA. The greater part of 5-HT formed in the body is excreted as 5-HIAA which can be comparatively simply estimated in the urine. The-normal excretion is within the range of 3-14 mg./24 hours. Determination of urinary 5-HIAA has proved a useful method for detecting 5-HT over-production, and several cases have been studied (Macfarlane et al., 1956) . Table I summarizes the findings in cases of argentaffinoma in which it was known that tumour tissue had not been eradicated by operation. The urinary excretion of 5-HIAA is significantly increased in them all and yet this is not associated with any constant clinical picture or with a particular distribution of tumour tissue. The findings, however, indicate that the assay of urinary 5-HIAA is useful in diagnosis. Table II summarizes the findings in several cases in which the diagnosis of argentaffinoma seemed possible. Case 6 is particularly interesting and has been reported elsewhere . In it the high urinary excretion of 5-HIAA confirms the tentative clinical diagnosis of argentaffinoma in spite of negative histochemical tests on tumour material from the liver and a bony metastasis. The latter tissue was, however, shown to contain a high content of 5-HT.
In the other cases in Table II the normal excretion of 5-HIAA, of course, suggests that they are not cases of argentaffinoma. Multiple colonic tumours 3 adeno-carcinomata 11-3 1-? argentaffinoma Specific stainsnegative 9
Cases of flushing and --10 cyanosis of unknown less than 11 origin ) 10 12
Spasmodic flushing: 5-2 Mass in right iliac fossa
The assay of 5-HIAA in urine is also indicated in cases of argentaffinoma after surgical treatment, but in such circumstances the sensitivity of the test, in terms of its ability to indicate early metastatic growth, has not yet been established.
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Mr. Adam N. Smith (Department of Surgery, University of Glasgow, at Western Infirmary, Glasgow). (See Scot. med. J. (1957), 2, 24.) We have recently had the opportunity of examining the humoral effects of 5-hydroxytryptamine (5-HT) in 7 cases of metastasizing ileal argentaffinoma. The cases were showing in whole or in part the striking clinical picture of flushing with cyanosis, diarrheea, cardiac defects and occasional asthmatic-like attacks, now well recognized since its description by the Swedish workers from Malmo. All the cases were excreting very large quantities of 5 hydroxyindole acetic acid (5-HIAA), the oxidation product of 5-HT and niumerous other indole compounds (Macfarlane et al., 1956; . A. Metabolism of 5-HT in relationship to tryptophan nicotinic acid and dietary protein andfat (i) Tryptophan and protein.
-Normal individuals excrete 2-10 mg./day 5-HIAA: true endogenous 5-HT production is probably higher 10-20 mg., requiring a similar amount of tryptophan as precursor. The tryptophan intake of a normal adult is usually 500-1,000 mg./day, greatly in excess of the amount required for 5-HT formation. In cases of argentaffinoma excreting up to 500 mg./day, a major part of the tryptophan metabolism-may be utilized in the pathway of 5-HT formation. The metabolic aspects of one case were examined in detail by Drs. C. E. Dalgliesh and R. W. Dutton as follows:
On a protein intake of 82 grams/day the patient was in positive nitrogen balance. Nitrogen balance became negative on reducing protein intake to 31 grams/day; it was not restored by adding 500 mg. L-tryptophan/day to the 31 grams protein diet, but returned to its previous positive value on returning to the 82 grams protein diet. The negative nitrogen balance was therefore not due to a simple tryptophan deficiency. On the 82 grams/day protein diet, mean 5-HIAA excretion was 312 mg./day. This dropped to a mean of 224 mg./day on the 31 grams/day protein diet, rose to a mean of 301 mg./day on supplementing the diet with 500 mg. L-tryptophan and returned to a mean of 222 mg./day on returning to the low protein diet. The 500 mg. L-tryptophan/day added to the diet corresponded to the estimated tryptophan content of the 51 grams/day drop in protein content of the diet between the two stages. Of this 500 mg. tryptophan, approximately one-fifth appeared as urinary 5-HIAA. It follows that a larger amount than this was probably metabolized by the 5-HT pathway. On the low protein diet the tryptophan intake was only of the order of 300-400 mg./day and probably more than two-thirds of this was metabolized by the 5-HT pathway.
These findings are best explained by assuming that the tumour has a basic rate of production of 5-HT, and will draw on circulating plasma tryptophan till this basic production is satisfied. Increase in available tryptophan may increase the rate of production of 5-HT by the tumour slightly, but not in proportion to the increased availability. Until the basic tumour production of 5-HT is satisfied the tumour may exert priority for available circulating tryptophan over protein biosynthesis and at low levels of protein intake an argentaffinoma may seriously impair the nutritional status of a patient.
(ii) Nicotinic acid deficiency.-Tryptophan is a precursor of nicotinic acid. If excess production of 5-HT by tumour tissue were to take priority for available supplies of tryptophan over protein synthesis and nicotinic acid formation, a serious nutritional deficiency might result. In fact pellagra-like symptoms have been claimed in this syndrome McNeely and Jones, 1946) . One of our cases showed symptoms which could well be those of nicotinic acid deficiency. She had had diarrheea intermittently for two to three months. Another patient complained of recurrent mouth ulcers with violet discoloration of the extremities.
The average diet in this country contains enough tryptophan to supply large demands by a tumour for 5-HT synthesis and yet still have enough for ordinary protein anabolism and nicotinic acid synthesis as well. In addition, patients with argentaffinomatosis may have diarrhoea and it seems likely that this may be important as a cause of the deficiency.
(iii) Evidence for alimentary control of i/elease of 5-HT by fat, &c.-Bleehen (1955) claimed that a fatty meal in his patient not only caused flushing but also raised the excretion of 5-HIAA. The time relations were such that a direct effect on the tumour of the products of absorption seemed unlikely: what seemed probable was the production in the stomach or duodenum of some intermediate hormone liberating 5-HT. It seemed important to confirm Bleehen's findings since by analogy it could be postulated that the discharge of 5-HT by the normal argentaffin cell might depend on a similar stimulus. Four patients were placed on a high fat diet for five days each. There was a substantial fall in 5-HIAA excretion and it is thus disappointing not to be able to confirm Bleehen's observation B. Trial of antagonists and 5-HT r eleasing agents Brominated lysergic acid (B.O.L.) (Cerletti and Rothlin, 1955) antagonizes 5-HT without the disturbing effects on cerebral function of the other related drugs.
It had little effect clinically on our cases; in one case there appeared to be a definite diminution of 5-HIAA excretion. Continuous administration of reserpine provoked an overall increase in frequency and intensity of flushes and frequency of bowel movements. There was a marked rise of 5-HIAA, followed by a fall in 5-HIAA excretion indicating a period of relative depletion in the tissues. This agent may prove useful as a provocative test in the non-secreting cases.
C. Blood and urinary levels of 5-HT and related cotmipounds Despite rapid conversion to 5-HIAA, a high blood level of 5-HT was found in all secreting cases (1-3-2 ,ug./ml.: normal range 0-08-06 ,ug./ml.). Despite the large numbers of indole compounds in the urine, in the typical case, 5-HT itself is not present or detectable, nor is the precursor 5-hydroxytryptophan (5 Htp). In one exceptional case with multiple metastases 5-HT and 5 Htp were both present in considerable amount in the urine. This represents a striking confirmation for the human subject of the accepted biochemistry of the condition, precursor, active substance and breakdown product having presumably "leaked out" together into the urine from a renal metastatic site.
D. Finally a unique feature of the syndrome must surely be its protean nature; our cases presented as, or could have been confused with, subacute intestinal obstruction with diarrhoea, ulcerative colitis, Raynaud phenomenon, cardiac defects, multiple sarcomata, oliguria and menopausal flushing. the tumour may be achieved by surgery we must rely for diagnosis on the local effects of the primary tumour. In the commonest site of occurrence-the appendix-these tumours are almost invariably associated with obliteration of the lumen, although the exact relationship of the tumour to the obstruction is not entirely clear. Symptoms of appendicular colic or of appendicitis are usually present and cause the patient to have appropriate treatment before metastases have occurred. In the rectum, obstructive symptoms are rare but in more than half of the reported cases without evidence of metastases there have been abdominal symptoms that have directed attention to the rectum. The commonest single complaint has been rectal bleeding, in contrast to the rarity of hemorrhage from carcinoid tumours in other sites. The other principal symptoms have been rectal pain and some alteration in bowel habit. The number of rectal carcinoids reported has more than doubled since the Section was addressed on this subject in 1950 by Mr. R. W. Raven, and the high proportion of symptomless, non-metastasizing carcinoids reported in this situation probably reflects the greater accessibility of the rectum rather than a lesser tendency towards malignancy. The most important group of tumours are those occurring in the small bowel. As with other small bowel neoplasms symptoms of disturbed intestinal function are of relatively late occurrence, and although the symptoms and signs of partial obstruction were present in almost twothirds of 200 metastases were already present in two-thirds of this obstructed group. Therefore, although argentaffinomata are particularly liable to cause intestinal obstruction, this tendency is not great enough to enhance the likelihood of early diagnosis.
Diarrhoea is less common than obstruction, being present in only one-quarter of the series of small bowel carcinoids reviewed, but is of more sinister import than obstruction in that of the 52 cases with diarrhoea all but 4 had metastases and most had hepatic as well as nodal secondaries. This suggests a predominantly humoral causation.
The characteristic feature of intestinal function in this syndrome is continuous activity of the gut. The increased motility is unrelated to the presence of obstruction and in the presence of widespread metastases continues after resection of the primary tumour. Increased borborygmi are present even in the absence of diarrhoea. Although typical, this excessive activity is by no means pathognomonic. A test which may ultimately prove to be more selective in patients having an unusually active gut depends on the effect on the intestine of ganglion-blocking agents such as hexamethonium bromide. From preliminary observations it seems likely that in individuals with hypermotility of the gut from various causes other than an excess of 5-hydroxytryptamine, peristalsis can be temporarily arrested by doses of these drugs that will not abolish peristalsis in patients with argentaffinomata. This is in keeping with the work of Robertson (1953) and of Rocha e Silva and Ribiero do Valle (1953) who showed that hexamethonium does not antagonize, and may even augment, the effect of 5-hydroxytryptamine on the guinea-pig ileum.
The occasional association of pellagra with the syndrome of metastasizing argentaffinoma has been noted. Of the 5 patients with this syndrome whom I have seen, none has had severe diarrhoea and none bas shown any evidence of nicotinic acid deficiency. The patient with severe pellagra and metastasizing argentaffinoma recorded by McNeely and Jones (1946) was passing up to 20 stools daily. One of the cases reported by showed signs and symptoms compatible with pellagra and this patient had suffered from diarrhoea for several months. It seems likely that the diarrhoea rather than the metabolic parasitism of the tumour is the principal factor in the development of a deficiency state. It is possible, too, that 5-hydroxytryptamine may prove to have some more direct relation to pigment metabolism than through its occasional association with pellagra. A patient of Sir James Learmonth with an abdominal mass which proved to be a metastasis from an ileal carcinoid had a daily urine output of from 500 ml. to 700 ml. in the absence of any evidence of fluid retention. This observation, in the light of Erspamer and Ottolenghi's (1952) work in which they found 5-hydroxytryptamine to be highly antidiuretic, first led me to suggest that disturbances of renal function and, in particular, periodic oliguria, might constitute yet another facet of this syndrome. A search of the literature lent scant support to this idea. In the few cases where urinary findings have been recorded they have been unremarkable except in some rare instances of direct involvement of the urinary tract by the pathological process, as in the classical case shown by Sir Maurice Cassidy in 1930. The solitary exception to this statement is the case reported by Snow et al. (1955) in which attacks of flushing and weakness were associated on at least one occasion with complete anuria lasting for four hours. In April 1956 I had the opportunity of visiting Professor Waldenstrom's clinic in Malmio where the significance of the syndrome was first recognized , and found that a number of their patients had showed periods of oliguria lasting for five or six days during which the urinary output approached the "volume obligatoire". A similar observation has recently been reported by Smith et al. (1957) . There does not seem to be any correlation between severity of symptoms and the occurrence of oliguria although in Smith's cases the oliguria was noted in the 2 patients having the most severe vasomotor manifestations. Renal function tests carried out in the 5 cases available to me have not disclosed any particular deviation from normal except in 1 patient with right ventricular failure. To investigate further the possible antidiuretic activity of 5-hydroxytryptamine in man, I observed the effects on maximal water diuresis of reserpine, which is believed to release 5-hydroxytryptamine, and later of 5-hydroxytryptamine itself. The technique used was the rapid intravenous infusion of isotonic dextrose in a volume equal to about 2% of the total body water (in practice about 850 ml.). Urine was collected at thirty-minute intervals throughout the experiment. Whereas in normal subjects an intramuscular injection of reserpine in doses of 1 mg. to 2 mg. given one or two hours before the test did not modify the diuretic response in any way (Fig. 1) , the same test in patients suffering from metastasizing argentaffinoma revealed a consistent reduction in the total response (Fig. 2) . It was not possible to detect any significant change in the urinary output of 5-hydroxyindole acetic acid as a result of the injection of reserpine in this dosage.
The dose of 5-hydroxytryptamine which can be given by intravenous injection in man is limited by the unpleasant subjective sensations (tightness in the chest, flushing and tingling, and increased bowel and bladder activity) and by the development of extrasystoles. When doses up to the limit of tolerance were given by slow intravenous injection simultaneously with a water load in normal subjects no significant modification of the pattern of diuretic response was observed although the duration of diuresis tended to be shortened . Because inhibition of a maximal water diuresis requires very great antidiuretic activity the effects of 5-hydroxytryptamine were tested during constant secretion at lower rates. The response was negative (Fig. 5) .
In view of these equivocal results the earlier experimental work was reviewed. Most of this work was based on the subcutaneous injection of the test substance in conscious rats (Erspamer and Ottolenghi, 1952) . Not only are subcutaneous injections unreliable in the assay of antidiuretic activity but 5-hydroxytryptamine tends to be extremely painful when injected, and any painful stimulus will produce powerful antidiuresis. In the only reported experiments in which intravenous injections of 5-hydroxytryptamine have been given to .anesthetized rats antidiuresis was not observed (Ames and Van Dyke, 1952) . In these experiments urine collections were made at ten-minute intervals, and it appeared worth while to repeat this work using more sensitive methods. This was done in conjunction with Mr. H. A. F. Dudley, using a modification of the method described by Jeffers et al. (1942) . The test substance is injected into the femoral vein of the alcohol-anesthetized hydrated rat, the rate of urine flow being measured by the rate of advance of the meniscus along a micropipette attached to a cystostomy tube after ligature of the urethra. In this highly sensitive preparation the effect of 5-hydroxytryptamine was constant and reproducible (Fig. 6 ). Within ten seconds of injection there was a sharp drop in the rate of urine flow but this effect always passed off within three minutes. Moreover, whereas serum from a normal individual did not have any effect on this preparation, serum from a patient with metastasizing argentaffinoma had an effect comparable to that produced by 5-hydroxytryptamine (Fig. 7) .
The doses of 5-hydroxytryptamine necessary to produce this transitory effect (in the order of 0 5 pg./100 grams) were comparable to those found by Erspamer and Ottolenghi (1953) to have a prolonged and profound antidiuretic effect. Taken in conjunction with Abrahams' and Pickford's (1956) carefully controlled studies which failed to disclose in dogs any antidiuretic effect from doses of 5-hydroxytryptamine which did not also produce marked reflex disturbances of respiration and vasomotor activity, these results suggest that Erspamer's (1954 Erspamer's ( , 1955 concept of 5-hydroxytryptamine as a specific renal hormone is unlikely to be correct. Whether the occasional periodic oliguria observed clinically is related to a direct effect of 5-hydroxytryptamine remains for the present uncertain. which at one time was thought to play a role in intestinal cancer, but this is still uncertain. Indolylacetic acid, which is produced from tryptamine, is the plant growth hormone auxin B. In cases with a rare metabolic disease, Hartnup disease, indolylacetic acid is excreted to such an extent that a shortage of tryptophan for nicotinic acid formation occurs (Baron et al., 1956) . The ensuing nicotinic acid deficiency is often associated with pellagra-like symptoms. Patients with Hartnup disease resemble those with carcinoids in that they sometimes develop pellagra-like symptoms.
The major metabolic pathway of tryptophan in normal mammals leads through kynurenine, 3-hydroxykynurenine 3-hydroxyanthranilic acid to nicotinic acid. We have been particularly interested in this process because 3-hydroxyanthranilic acid is carcinogenic when implanted in the bladders of mice and it may be a cause of cancer of the bladder in man (Allen et al., 1957) . A subsidiary metabolic route involving 3-hydroxykynurenine leads to formation of xanthurenic acid-a substance which is said to induce hyperglycemia and may be important in diabetes.
Our own approach to the carcinoid problem has been through interest in those tryptophan metabolites which may be of importance in cancer of the bladder. We (Boyland et al., 1956) have developed a method in which some 16 tryptophan metabolites were separated on paper chromatograms and their amounts estimated by the measurement of the areas of the spots produced by the different substances.
In most of the patients twenty-four-hour specimens of urine, collected under normal conditions and following administration of 2 g L-tryptophan, were examined. The administration of tryptophan reduces the variation in tryptophan intake due to differences in diet and increases the amounts of the metabolites excreted, so that abnormalities in excretion patterns are more easily seen.
The method applied to 3 patients with carcinoids gave results similar to those found by other workers. The urine of these patients did not contain abnormal amounts of any of the other possible tryptophan metabolites including anthranilic acid, 3-hydroxyanthranilic acid, 5-hydroxyanthranilic acid, 3-hydroxyanthranilic acid sulphuric ester, kynurenine, 3-hydroxykynurenine, tryptamine, and indoxyl sulphate.
The same tryptophan metabolites have been determined in the urine of patients with tumours of different sites. Patients with bladder cancer excrete increased amounts of 3hydroxyanthranilic acid and 3-hydroxykynurenine (Boyland and Williams, 1956) . In investigation of these substances it was found that patients with carcinomata of the vocal cord, pyriform fossa or bronchus excreted somewhat more 5-HT or 5-HIAA than did other patients, following administration of 2 g L-tryptophan. The amounts excreted were small compared with those of carcinoid patients but more than excreted by patients with cancer of the bladder or cancer of the breast or by subjects free of malignant disease. Excretion of 5-HIAA by a patient with cancer of the bronchus has recently been described by Harrison et al. (1957) . The administration of L-tryptophan to subjects before the collection of urine for examination undoubtedly increases the possibility of detecting metabolic abnormalities.
